The reliability, validity, discriminant and predictive properties of the social Phobia Inventory (SoPhI)

This paper reports on the psychometric properties of the Social Phobic Inventory (SoPhI) a 21-item scale that was designed to measure social anxiety according to the criteria of DSM-IV (American Psychiatric Association, APA (1994) Diagnostic and Statistical Manual of Mental Disorder , 4th Edn., Washington). Factor analysis of the SoPhI using data from a clinical sample of respondents with social phobia revealed one factor which explained approximately 59% of variance and which demonstrated strong internal reliability ( agr= 0.93). The SoPhI demonstrated concurrent validity with the SPAI ( r = 0.86) and convergent validity with the Fear of Negative Evaluations-Revised ( r = 0.68). The predictive utility of the scale was demonstrated in a sample of university students classified as extroverted, normal, shy/introverted, and phobic/withdrawn ( -2 57%). Multivariate Analysis of Variance (MANOVA) revealed that the combined university sample differed from the clinical sample on the summated scores on the SoPhI and that 43% ( -2 ) of this difference was attributable to group membership. This figure rose to 58% attributable to group membership when these same groups were compared for differences on the 21 individual items. Scores of the SoPhI that are indicative of concern and of possible diagnostic criteria, as well as suggestions for future research, are discussed.

The impact of social phobia on quality of life: the advantages of anxiety support groups

Social phobia is the least well known of the anxiety disorders and it is perhaps also the least well understood. The lifetime prevalence rates for social phobia, which range from 3% to 13%, clearly indicate that social phobia is a widespread mental health problem. Those affected by social phobia often live their lives around the limitations of the disorder including avoidance of social situations, depression and loneliness. Thus for these individuals, social phobia becomes an impairing disorder which can have long-term negative impacts on work performance and social relationships. Anxiety support groups offer an important resource to sufferers of social phobia. Support groups provide a potentially safe and confidential environment in which to interact with others. Support groups also have the potential to help to de-stigmatize the disorders for sufferers as all members share similar concerns that are often not well understood by others. The practical benefits to be derived from anxiety support groups are presented through the discussion of two case studies.

Efeitos de uma intervenção comportamental com treino de habilidades sociais para universitários com fobia social

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Public Speaking in Social Phobia: A Pilot Study of Self-Ratings and Observers' Ratings of Social Skills

Objectives: The aim of this pilot study was to investigate whether patients with social anxiety disorder (SAD) differ from controls in the quality of skill-related behaviors displayed during a speech and in overall behavioral adequacy as perceived by observers and by the patients themselves. Design: A total of 18 SAD patients and 18 controls were screened by a diagnostic interview and took part in a 3-minute speech of their own choosing. For each videotaped speech, observers rated the adequacy of the skill-related behaviors and overall performance adequacy. After the experiment, participants were asked to rate their own overall performance adequacy. Results: The results showed that SAD patients exhibited significantly worse voice intonation and fluency of the speech, however no differences were found in global self-ratings. Moreover, the performance evaluations of the SAD group were consistent with the observers, while the controls evaluated their performance lower than the observers. Conclusions: The results are inconsistent with the cognitive model, because patients with SAD did not underestimate their performance. Compared with spontaneous interactions, the clear rules established for such social situations as speeches may result in less cognitive distortion for SAD patients. (C) 2012 Wiley Periodicals, Inc. J. Clin. Psychol. 68:397-402, 2012.

Relationship among social support, treatment adherence and metabolic control of diabetes mellitus patients

This cross-sectional and quantitative study aimed to analyze the relationship among social support, adherence to non-pharmacological (diet and physical exercise) and pharmacological treatments (insulin and/or oral anti-diabetic medication) and clinical and metabolic control of 162 type 2 diabetes mellitus patients. Data were collected through instruments validated for Brazil. Social support was directly correlated with treatment adherence. Adherence to non-pharmacological treatment was inversely correlated with body mass index, and medication adherence was inversely correlated with diastolic blood pressure. There were no associations between social support and clinical and metabolic control variables. Findings indicate that social support can be useful to achieve treatment adherence. Studies with other designs should be developed to broaden the analysis of relations between social support and other variables.

The etiology of social phobia: Empirical evidence and an initial model

Research into the etiology of social phobia has lagged far behind that of descriptive and maintaining factors. The current paper reviews data from a variety of sources that have some bearing on questions of the origins of social fears. Areas examined include genetic factors, temperament, childrearing, negative life events, and adverse social experiences. Epidemiological data are examined in detail and factors associated with social phobia such as cognitive distortions and social skills are also covered. The paper concludes with an initial model that draws together some of the current findings and aims to provide a platform for future research directions. (C) 2004 Elsevier Ltd. All rights reserved.

Les effets à long terme d'une approche interpersonnelle pour le traitement de la phobie sociale : un suivi de 8 à 15 ans.

La phobie sociale est le plus souvent décrite comme suivant une trajectoire chronique. Afin de modifier ce cours clinique, plusieurs protocoles de traitement ont été développés, leur efficacité ayant été démontrée dans de nombreuses études. Toutefois, est-ce que les gains rapportés se maintiennent des années suivant la fin du traitement? Cette dissertation avait pour objectif d’examiner cette question. Une recension d’études a d’abord permis d’effectuer une analyse critique des évidences relatives à la durabilité des effets thérapeutiques des traitements contemporains. Cette recension a permis de constater que les études ayant inclus une période de suivi excédant un an sont peu nombreuses. Lorsque de telles études ont été recensées, la réduction de l’anxiété s’est avérée la retombée thérapeutique principalement investiguée. Les évidences demeurent parcellaires concernant la durabilité des gains sur d’autres dimensions de la phobie sociale, en l’occurrence le fonctionnement social, et quant au maintien de la rémission. Pour combler ces lacunes, la durabilité des gains thérapeutiques, 8 à 15 ans suivant la fin d’un traitement d’approche interpersonnelle (AI), a été évaluée. Cette approche vise la dissolution du pattern global d’auto-protection, en améliorant la participation sociale et en facilitant le développement de modes relationnels plus adaptés. Cinquante-huit individus, satisfaisant initialement les critères de la phobie sociale, ont pris part à cette étude. Ces derniers ont rapporté des gains significatifs, jusqu’à une relance d’un an suivant la fin du traitement. L’évolution de l’anxiété sociale, de la détresse générale et du fonctionnement social, de la relance d’un an à la relance de 8 à 15 ans, a donc été évaluée. La signification statistique et clinique des effets obtenus dans le temps, de même que les différences individuelles, ont été examinées. Les résultats révèlent que le protocole de traitement AI a produit des effets durables depuis la relance d’un an sur les variables examinées. La plupart des participants en rémission à la relance d’un an l’étaient encore une dizaine d’années plus tard. Les participants ayant rapporté une réduction cliniquement significative de la détresse sociale un an suivant la fin du traitement ont connu une trajectoire similaire. Une augmentation significative du taux de rémission a également été constatée. Une analyse fonctionnelle a d’ailleurs révélé une amélioration des répertoires de comportements sociaux chez la majorité des participants, suggérant une dynamique de changement reflétant le passage de l’auto-protection à la participation sociale. Par ailleurs, une hypothèse issue de la perspective interpersonnelle de la phobie sociale et de son traitement a été étayée : une convergence des changements relevés sur les dimensions anxieuse et interpersonnelle a été notée. En somme, l’ensemble de ces résultats soutient l’efficacité à long terme du traitement AI.

Case-series Evaluating a Transdiagnostic Cognitive-behavioral Treatment For Co-occurring Anxiety Disorders.

Background. Patients with anxiety disorder diagnoses commonly have more than one anxiety diagnosis. While cognitive-behavioral interventions have proven efficacy in treating single anxiety disorder diagnoses, there has been little investigation of their efficacy in treating cooccurring anxiety disorders. Aims. To evaluate the efficacy of a transdiagnostic cognitive-behavioral intervention for treating co-occurring anxiety disorders. Methods. An A-B single case study design (N = 6) was used to evaluate the efficacy of a 12 to 13 session modular transdiagnostic cognitive-behavioral intervention for treating co-occurring anxiety disorders across patients with at least two of the following diagnoses: GAD, Social Phobia, Panic Disorder and/or OCD. Results. Five of the six participants completed treatment. At post-treatment assessment the five treatment completers achieved diagnostic and symptomatic change with three participants being diagnosis free. All participants who completed treatment no longer met criteria for any DSM-IV-TR Axis-I diagnosis at the three-month follow-up assessment, and demonstrated reliable and clinically-significant improvements in symptoms. Across the participants, statistically significant improvements from pre- to post-intervention were found on measures of anxiety, depression and general well-being, and all improvements were maintained at three-month follow-up. Conclusions. Results suggest that transdiagnostic cognitive behavioral interventions can be of benefit to patients with co-occurring anxiety disorders.

Treatment response in child anxiety is differentially related to the form of maternal anxiety disorder

An examination was made of the extent to which maternal anxiety predicted response to treatment of children presenting with an anxiety disorder. In a sample of 55 children referred to a local NHS CAMH service for treatment of an anxiety disorder, systematic mental state interview assessment was made of both mothers and children, and both completed self-report questionnaires to assess aspects of anxiety, both immediately before the children received treatment and following treatment. Children of mothers with anxiety disorder overall responded less well to treatment than children of mothers with no anxiety disorder. There was some diagnostic specificity in this in that children of mothers with GAD did as well in treatment as children whose mothers had no anxiety, whereas children of mothers with social phobia did poorly. The outcome for children with anxiety appears to be related to the presence and nature of maternal anxiety. It would seem prudent that treatment of children with anxiety involves assessment of maternal anxiety. It is important to establish in systematic investigation whether treatment of maternal anxiety improves the outcome for child anxiety.

The relationship between social anxiety and alcohol use in remand prisoners

Community studies have found a consistently high co-occurrence, between alcohol use and anxiety disorders, such as social phobia. Despite high prevalence rates of alcohol use and anxiety disorders in remand prisoners, the extent to which they co-occur in this population and the use of alcohol as a strategy to reduce social anxiety, have not been examined. The aim of this study was to assess levels of social phobia and the use of alcohol to reduce anxiety associated with social and performance situations in a remanded prison population. One hundred and one male prisoners (age M = 34.88 years, SD = 11.70) participated in the study. They completed the Social Phobia Inventory (SoPhI) and a questionnaire designed to assess levels of drinking in social and performance situations to reduce anxiety. High levels of social anxiety were found, together with high levels of drinking to reduce anxiety associated with social or performance situations. Drinking was predictive of reduced levels of social anxiety but the effect of social anxiety on drinking was stronger. The implications for treatment and future research are discussed.